JANNEY DANIEL
Insider CIK 1198325 · AGTC 10% owner · AERI 10% owner · LIFE 10% owner · CBYL 10% owner · STRO Director, 10% owner · TRVN 10% owner · ESPR Director, 10% owner · IMDZ 10% owner · ZSPH 10% owner · ALLK Director, 10% owner · NEOT Director, 10% owner · KRYS Director · TYRA 10% owner · PLCSD Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KRYS Krystal Biotech, Inc. | A Award deriv | 2026-09-14 | 2026-09-16 | 1,187 | — | $0 | 1,187 | SEC↗ |
| KRYS Krystal Biotech, Inc. | A Award deriv | 2026-09-14 | 2026-09-16 | 471 | — | $0 | 471 | SEC↗ |
| KRYS Krystal Biotech, Inc. | A Award deriv | 2026-09-14 | 2026-09-16 | 471 | — | $0 | 471 | SEC↗ |
| KRYS Krystal Biotech, Inc. | A Award deriv | 2026-09-14 | 2026-09-16 | 1,187 | — | $0 | 1,187 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2026-02-27 | 2026-03-03 | 9,430 | $275.45 | $2.60M | 75,666 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2026-02-27 | 2026-03-03 | 2,373 | $276.17 | $655.4K | 73,293 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2026-02-26 | 2026-02-26 | 5,103 | $275.28 | $1.40M | 87,734 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2026-02-26 | 2026-02-26 | 2,638 | $276.32 | $728.9K | 85,096 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2026-02-25 | 2026-02-26 | 700 | $275.00 | $192.5K | 92,837 | SEC↗ |
| KRYS Krystal Biotech, Inc. | M Exercise deriv | 2026-02-24 | 2026-02-26 | 37,895 | — | $0 | 0 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2026-02-24 | 2026-02-26 | 3,963 | $268.97 | $1.07M | 743 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2026-02-24 | 2026-02-26 | 6,671 | $268.04 | $1.79M | 4,706 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2026-02-24 | 2026-02-26 | 11,673 | $266.97 | $3.12M | 11,377 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2026-02-24 | 2026-02-26 | 8,986 | $266.18 | $2.39M | 23,050 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2026-02-24 | 2026-02-26 | 3,557 | $265.08 | $942.9K | 32,036 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2026-02-24 | 2026-02-26 | 1,733 | $264.12 | $457.7K | 35,593 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2026-02-24 | 2026-02-26 | 569 | $262.91 | $149.6K | 37,326 | SEC↗ |
| KRYS Krystal Biotech, Inc. | M Exercise | 2026-02-24 | 2026-02-26 | 37,895 | $2.46 | $93.2K | 37,895 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2026-02-24 | 2026-02-26 | 370 | $269.83 | $99.8K | 373 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2026-02-24 | 2026-02-26 | 373 | $271.09 | $101.1K | 0 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2026-02-24 | 2026-02-26 | 62 | $263.05 | $16.3K | 107,300 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2026-02-24 | 2026-02-26 | 900 | $264.60 | $238.1K | 106,400 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2026-02-24 | 2026-02-26 | 1,604 | $265.54 | $425.9K | 104,796 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2026-02-24 | 2026-02-26 | 4,339 | $266.62 | $1.16M | 100,457 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2026-02-24 | 2026-02-26 | 1,891 | $267.37 | $505.6K | 98,566 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2026-02-24 | 2026-02-26 | 930 | $269.50 | $250.6K | 95,962 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2026-02-24 | 2026-02-26 | 1,674 | $268.67 | $449.8K | 96,892 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2026-02-24 | 2026-02-26 | 2,425 | $274.90 | $666.6K | 93,537 | SEC↗ |
| KRYS Krystal Biotech, Inc. | A Award deriv | 2025-06-30 | 2025-06-30 | 5,000 | — | $0 | 5,000 | SEC↗ |
| KRYS Krystal Biotech, Inc. | A Award deriv | 2024-06-30 | 2024-07-01 | 5,000 | — | $0 | 5,000 | SEC↗ |
| KRYS Krystal Biotech, Inc. | A Award deriv | 2023-06-30 | 2023-07-03 | 6,800 | — | $0 | 6,800 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2023-06-09 | 2023-06-09 | 10,000 | $128.53 | $1.29M | 107,362 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2023-06-09 | 2023-06-09 | 5,000 | $128.84 | $644.2K | 117,362 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2023-06-09 | 2023-06-09 | 3,935 | $129.29 | $508.8K | 122,362 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2023-06-08 | 2023-06-09 | 5,000 | $127.86 | $639.3K | 126,297 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2023-06-08 | 2023-06-09 | 10,000 | $127.96 | $1.28M | 131,297 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2023-06-08 | 2023-06-09 | 5,000 | $127.96 | $639.8K | 141,297 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2023-06-08 | 2023-06-09 | 5,388 | $128.73 | $693.6K | 146,297 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2023-06-08 | 2023-06-09 | 1,073 | $129.02 | $138.4K | 151,685 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2023-06-08 | 2023-06-09 | 4,604 | $127.96 | $589.1K | 152,758 | SEC↗ |
| ALLK Allakos Inc. | A Award deriv | 2023-05-25 | 2023-05-30 | 86,762 | — | $0 | 86,762 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2023-05-19 | 2023-05-23 | 50,000 | $95.02 | $4.75M | 157,362 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2023-05-09 | 2023-05-11 | 17,100 | $90.74 | $1.55M | 207,362 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2023-04-19 | 2023-04-21 | 7,900 | $90.32 | $713.5K | 224,462 | SEC↗ |
| ALLK Allakos Inc. | P Buy | 2022-09-21 | 2022-09-23 | 475,000 | $5.02 | $2.38M | 2,546,147 | SEC↗ |
| KRYS Krystal Biotech, Inc. | A Award deriv | 2022-06-30 | 2022-07-01 | 6,800 | — | $0 | 6,800 | SEC↗ |
| ALLK Allakos Inc. | A Award deriv | 2022-05-25 | 2022-05-27 | 99,590 | — | $0 | 99,590 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2021-12-10 | 2021-12-14 | 100,000 | $70.50 | $7.05M | 266,362 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | C Conversion deriv | 2021-09-17 | 2021-09-17 | 1,212,122 | — | $0 | 0 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | C Conversion deriv | 2021-09-17 | 2021-09-17 | 255,160 | — | $0 | 0 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | C Conversion | 2021-09-17 | 2021-09-17 | 3,811,117 | — | $0 | 3,924,046 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | P Buy | 2021-09-17 | 2021-09-17 | 156,250 | $16.00 | $2.50M | 4,080,296 | SEC↗ |
| KRYS Krystal Biotech, Inc. | A Award deriv | 2021-06-30 | 2021-07-02 | 6,800 | — | $0 | 6,800 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award | 2021-05-27 | 2021-05-28 | 12,376 | — | $0 | 23,449 | SEC↗ |
| ALLK Allakos Inc. | A Award deriv | 2021-05-25 | 2021-10-14 | 7,700 | — | $0 | 7,700 | SEC↗ |
| ALLK Allakos Inc. | S Sale | 2021-03-26 | 2021-03-30 | 14,808 | $115.01 | $1.70M | 58,793 | SEC↗ |
| ALLK Allakos Inc. | S Sale | 2021-03-26 | 2021-03-30 | 2,500 | $116.09 | $290.2K | 56,293 | SEC↗ |
| ALLK Allakos Inc. | S Sale | 2021-03-22 | 2021-03-24 | 4,118 | $120.22 | $495.1K | 73,601 | SEC↗ |
| ALLK Allakos Inc. | S Sale | 2021-03-22 | 2021-03-24 | 9,030 | $119.46 | $1.08M | 77,719 | SEC↗ |
| ALLK Allakos Inc. | S Sale | 2021-03-15 | 2021-03-16 | 6,708 | $124.56 | $835.5K | 86,749 | SEC↗ |
| ALLK Allakos Inc. | S Sale | 2021-03-12 | 2021-03-16 | 4,071 | $124.18 | $505.5K | 93,457 | SEC↗ |
| ALLK Allakos Inc. | S Sale | 2021-03-11 | 2021-03-11 | 6,006 | $124.62 | $748.5K | 97,528 | SEC↗ |
| ALLK Allakos Inc. | S Sale | 2021-03-09 | 2021-03-11 | 100 | $125.00 | $12.5K | 103,534 | SEC↗ |
| KRYS Krystal Biotech, Inc. | A Award deriv | 2020-06-30 | 2020-08-07 | 6,800 | — | $0 | 6,800 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award | 2020-05-28 | 2020-05-29 | 6,106 | — | $0 | 11,073 | SEC↗ |
| ALLK Allakos Inc. | A Award deriv | 2020-05-26 | 2020-05-28 | 7,700 | — | $0 | 7,700 | SEC↗ |
| ALLK Allakos Inc. | J Other | 2020-01-22 | 2020-01-24 | 11,538 | — | $0 | 11,538 | SEC↗ |
| ALLK Allakos Inc. | J Other | 2020-01-22 | 2020-01-24 | 11,539 | — | $0 | 11,539 | SEC↗ |
| ALLK Allakos Inc. | J Other | 2020-01-22 | 2020-01-24 | 11,538 | — | $0 | 11,538 | SEC↗ |
| ALLK Allakos Inc. | J Other | 2020-01-22 | 2020-01-24 | 6,837 | — | $0 | 6,837 | SEC↗ |
| ALLK Allakos Inc. | J Other | 2020-01-22 | 2020-01-24 | 34,615 | — | $0 | 0 | SEC↗ |
| ALLK Allakos Inc. | J Other | 2020-01-22 | 2020-01-24 | 34,615 | — | $0 | 34,615 | SEC↗ |
| ALLK Allakos Inc. | J Other | 2020-01-22 | 2020-01-24 | 1,000,000 | — | $0 | 10,519,200 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2019-08-30 | 2019-09-03 | 32,190 | $46.18 | $1.49M | 366,362 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2019-08-29 | 2019-09-03 | 700 | $47.50 | $33.3K | 398,552 | SEC↗ |
| KRYS Krystal Biotech, Inc. | S Sale | 2019-08-29 | 2019-09-03 | 55,794 | $46.61 | $2.60M | 399,252 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2019-06-17 | 2019-06-19 | 11,610 | — | $0 | 11,610 | SEC↗ |
| ALLK Allakos Inc. | A Award deriv | 2019-06-06 | 2019-06-11 | 16,000 | — | $0 | 16,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award | 2019-05-29 | 2019-05-31 | 4,967 | — | $0 | 4,967 | SEC↗ |
| VIVE VIVEVE MEDICAL, INC. | A Award | 2018-12-31 | 2019-01-02 | 21,131 | — | $0 | 60,579 | SEC↗ |
| VIVE VIVEVE MEDICAL, INC. | A Award deriv | 2018-10-23 | 2018-10-25 | 17,500 | — | $0 | 17,500 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 12,387,324 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 9,449,318 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 18,698,578 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 10,201,769 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 9,449,318 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 12,387,324 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 18,698,578 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 10,201,769 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 458,331 | — | $0 | 1,047,992 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 589,661 | — | $0 | 589,661 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 382,698 | — | $0 | 1,430,690 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 514,211 | — | $0 | 1,944,901 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 458,331 | — | $0 | 1,047,992 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 589,661 | — | $0 | 589,661 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 382,698 | — | $0 | 1,430,690 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 514,211 | — | $0 | 1,944,901 | SEC↗ |
| VIVE VIVEVE MEDICAL, INC. | A Award | 2018-10-01 | 2018-10-04 | 8,947 | — | $0 | 39,448 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | A Award deriv | 2018-09-26 | 2018-09-27 | 26,033 | — | $0 | 26,033 | SEC↗ |
| ALLK Allakos Inc. | C Conversion deriv | 2018-07-23 | 2018-07-23 | 10,030,193 | — | $0 | 0 | SEC↗ |
| ALLK Allakos Inc. | C Conversion deriv | 2018-07-23 | 2018-07-23 | 1,239,007 | — | $0 | 0 | SEC↗ |
| ALLK Allakos Inc. | C Conversion | 2018-07-23 | 2018-07-23 | 11,269,200 | — | $0 | 11,269,200 | SEC↗ |
| ALLK Allakos Inc. | P Buy | 2018-07-23 | 2018-07-23 | 250,000 | $18.00 | $4.50M | 11,519,200 | SEC↗ |
| VIVE VIVEVE MEDICAL, INC. | A Award | 2018-07-02 | 2018-07-03 | 8,437 | — | $0 | 30,501 | SEC↗ |
| KRYS Krystal Biotech, Inc. | A Award deriv | 2018-05-31 | 2018-06-04 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2018-05-23 | 2018-05-25 | 10,100 | — | $0 | 10,100 | SEC↗ |
| VIVE VIVEVE MEDICAL, INC. | A Award deriv | 2018-05-22 | 2018-05-23 | 17,500 | — | $0 | 17,500 | SEC↗ |
| VIVE VIVEVE MEDICAL, INC. | A Award | 2018-04-02 | 2018-04-04 | 6,450 | — | $0 | 22,064 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | J Other | 2018-02-28 | 2020-05-29 | 24,565 | — | $0 | 24,565 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | J Other | 2018-02-28 | 2019-05-31 | 24,565 | — | $0 | 24,565 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | M Exercise deriv | 2018-01-18 | 2018-01-22 | 71,237 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | M Exercise | 2018-01-18 | 2018-01-22 | 71,237 | $6.99 | $497.9K | 631,204 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | F Tax w/h | 2018-01-18 | 2018-01-22 | 6,640 | $74.96 | $497.7K | 624,564 | SEC↗ |
| VIVE VIVEVE MEDICAL, INC. | A Award | 2018-01-02 | 2018-01-04 | 4,276 | — | $0 | 15,614 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | G Gift | 2017-12-29 | 2018-01-22 | 31,466 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | G Gift | 2017-12-29 | 2018-01-22 | 7,020 | — | $0 | 0 | SEC↗ |
| VIVE VIVEVE MEDICAL, INC. | A Award | 2017-10-02 | 2017-10-04 | 2,872 | — | $0 | 11,338 | SEC↗ |
| KRYS Krystal Biotech, Inc. | C Conversion deriv | 2017-09-22 | 2017-09-25 | 124,456 | — | $0 | 0 | SEC↗ |
| KRYS Krystal Biotech, Inc. | C Conversion | 2017-09-22 | 2017-09-25 | 124,456 | — | $0 | 455,046 | SEC↗ |
| KRYS Krystal Biotech, Inc. | P Buy | 2017-09-22 | 2017-09-25 | 200,000 | $10.00 | $2.00M | 330,590 | SEC↗ |
| VIVE VIVEVE MEDICAL, INC. | A Award deriv | 2017-09-06 | 2017-09-08 | 17,500 | — | $0 | 17,500 | SEC↗ |
| VIVE VIVEVE MEDICAL, INC. | A Award | 2017-09-06 | 2017-09-08 | 3,025 | — | $0 | 8,466 | SEC↗ |
| VIVE VIVEVE MEDICAL, INC. | A Award | 2017-05-17 | 2017-05-19 | 2,387 | — | $0 | 5,441 | SEC↗ |
| VIVE VIVEVE MEDICAL, INC. | A Award | 2017-05-17 | 2017-05-19 | 2,387 | — | $0 | 5,441 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2017-04-17 | 2017-04-19 | 14,000 | — | $0 | 14,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2017-03-21 | 2017-03-23 | 700 | $48.19 | $33.7K | 1,359,967 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2017-03-21 | 2017-03-23 | 56,855 | $47.54 | $2.70M | 1,360,667 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2017-03-21 | 2017-03-23 | 59,798 | $46.60 | $2.79M | 1,417,522 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2017-03-21 | 2017-03-23 | 111,307 | $45.43 | $5.06M | 1,477,320 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2017-03-21 | 2017-03-23 | 121,340 | $44.91 | $5.45M | 1,588,627 | SEC↗ |
| VIVE VIVEVE MEDICAL, INC. | P Buy | 2017-03-17 | 2017-03-21 | 500,000 | $4.00 | $2.00M | 1,381,955 | SEC↗ |
| VIVE VIVEVE MEDICAL, INC. | A Award deriv | 2016-12-23 | 2016-12-28 | 11,035 | — | $0 | 11,035 | SEC↗ |
| VIVE VIVEVE MEDICAL, INC. | A Award | 2016-11-09 | 2016-11-14 | 1,775 | — | $0 | 3,054 | SEC↗ |
| VIVE VIVEVE MEDICAL, INC. | A Award deriv | 2016-08-22 | 2016-08-24 | 4,590 | — | $0 | 4,590 | SEC↗ |
| VIVE VIVEVE MEDICAL, INC. | A Award | 2016-08-22 | 2016-08-24 | 1,279 | — | $0 | 1,279 | SEC↗ |
| VIVMF VIVEVE MEDICAL, INC. | P Buy | 2016-06-17 | 2016-06-20 | 200,000 | $5.00 | $1.00M | 881,954 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2016-06-09 | 2016-06-10 | 8,000 | — | $0 | 8,000 | SEC↗ |
| VIVMF VIVEVE MEDICAL, INC. | P Buy deriv | 2016-01-27 | 2016-01-29 | 202,000 | $0.35 | $70.7K | 202,000 | SEC↗ |
| NEOT Neothetics, Inc. | S Sale | 2015-12-30 | 2015-12-30 | 250,000 | $1.44 | $360.0K | 1,339,776 | SEC↗ |
| NEOT Neothetics, Inc. | S Sale | 2015-12-29 | 2015-12-30 | 493,654 | $1.53 | $755.3K | 1,589,776 | SEC↗ |
| NEOT Neothetics, Inc. | S Sale | 2015-12-28 | 2015-12-30 | 54,333 | $1.59 | $86.4K | 2,083,430 | SEC↗ |
| VIVMF VIVEVE MEDICAL, INC. | A Award deriv | 2015-12-16 | 2015-12-18 | 108,000 | — | $0 | 155,000 | SEC↗ |
| NEOT Neothetics, Inc. | S Sale | 2015-12-15 | 2015-12-17 | 529,261 | $1.44 | $762.1K | 2,137,763 | SEC↗ |
| VIVMF VIVEVE MEDICAL, INC. | P Buy | 2015-11-24 | 2015-11-25 | 857,142 | $0.70 | $600.0K | 5,455,632 | SEC↗ |
| NEOT Neothetics, Inc. | A Award deriv | 2015-06-16 | 2015-06-17 | 12,450 | — | $0 | 12,450 | SEC↗ |
| NEOT Neothetics, Inc. | A Award deriv | 2015-06-16 | 2015-06-17 | 23,940 | — | $0 | 23,940 | SEC↗ |
| ZSPH ZS Pharma, Inc. | S Sale | 2015-06-08 | 2015-06-09 | 11,200 | $57.53 | $644.3K | 2,646,643 | SEC↗ |
| ZSPH ZS Pharma, Inc. | S Sale | 2015-06-05 | 2015-06-09 | 164,227 | $57.88 | $9.51M | 2,657,843 | SEC↗ |
| ZSPH ZS Pharma, Inc. | S Sale | 2015-06-04 | 2015-06-05 | 48,913 | $57.71 | $2.82M | 2,822,070 | SEC↗ |
| ZSPH ZS Pharma, Inc. | S Sale | 2015-06-04 | 2015-06-05 | 39,495 | $57.21 | $2.26M | 2,870,983 | SEC↗ |
| ZSPH ZS Pharma, Inc. | S Sale | 2015-06-03 | 2015-06-05 | 23,189 | $56.60 | $1.31M | 2,910,478 | SEC↗ |
| ZSPH ZS Pharma, Inc. | S Sale | 2015-06-02 | 2015-06-02 | 84,342 | $56.77 | $4.79M | 2,933,667 | SEC↗ |
| ZSPH ZS Pharma, Inc. | S Sale | 2015-06-01 | 2015-06-02 | 72,520 | $58.00 | $4.21M | 3,018,009 | SEC↗ |
| ZSPH ZS Pharma, Inc. | S Sale | 2015-05-29 | 2015-06-02 | 124,865 | $58.63 | $7.32M | 3,105,225 | SEC↗ |
| ZSPH ZS Pharma, Inc. | S Sale | 2015-05-29 | 2015-06-02 | 14,696 | $59.69 | $877.2K | 3,090,529 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2015-05-14 | 2015-05-18 | 8,000 | — | $0 | 8,000 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-14 | 893,655 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-14 | 4,361,703 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-14 | 4,320,173 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-14 | 3,600,000 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-14 | 1,126,866 | — | $0 | 0 | SEC↗ |
| VIVMF VIVEVE MEDICAL, INC. | P Buy | 2015-05-12 | 2015-05-14 | 2,702,702 | $0.37 | $1000.0K | 4,598,490 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion | 2015-05-12 | 2015-05-14 | 1,685,758 | — | $0 | 1,685,758 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion | 2015-05-12 | 2015-05-14 | 92,306 | — | $0 | 1,778,064 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion deriv | 2015-04-14 | 2015-04-14 | 332,990 | — | $0 | 0 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion deriv | 2015-04-14 | 2015-04-14 | 727,590 | — | $0 | 0 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion deriv | 2015-04-14 | 2015-04-14 | 1,981,124 | — | $0 | 0 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion deriv | 2015-04-14 | 2015-04-14 | 424,346 | — | $0 | 0 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion | 2015-04-14 | 2015-04-14 | 424,346 | — | $0 | 3,133,060 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion | 2015-04-14 | 2015-04-14 | 1,981,124 | — | $0 | 2,708,714 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion | 2015-04-14 | 2015-04-14 | 727,590 | — | $0 | 727,590 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | P Buy | 2015-04-14 | 2015-04-14 | 877,500 | $5.00 | $4.39M | 4,343,550 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion | 2015-04-14 | 2015-04-14 | 332,990 | — | $0 | 3,466,050 | SEC↗ |
| TRVN TREVENA INC | P Buy | 2014-12-10 | 2014-12-10 | 500,000 | $4.00 | $2.00M | 4,390,262 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-11-25 | 750,000 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-11-25 | 6,216,215 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-11-25 | 2,201,220 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-11-25 | 4,489,065 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | X Exercise deriv | 2014-11-25 | 2014-11-25 | 707,142 | $1.40 | $990.0K | 0 | SEC↗ |
| NEOT Neothetics, Inc. | X Exercise deriv | 2014-11-25 | 2014-11-25 | 432,432 | $1.85 | $800.0K | 0 | SEC↗ |
| NEOT Neothetics, Inc. | X Exercise deriv | 2014-11-25 | 2014-11-25 | 214,285 | $1.40 | $300.0K | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion | 2014-11-25 | 2014-11-25 | 1,161,939 | — | $0 | 1,288,824 | SEC↗ |
| NEOT Neothetics, Inc. | P Buy | 2014-11-25 | 2014-11-25 | 70,000 | $14.00 | $980.0K | 2,667,024 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion | 2014-11-25 | 2014-11-25 | 476,845 | — | $0 | 1,765,669 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion | 2014-11-25 | 2014-11-25 | 735,912 | — | $0 | 2,501,581 | SEC↗ |
| NEOT Neothetics, Inc. | X Exercise | 2014-11-25 | 2014-11-25 | 93,676 | $11.29 | $1.06M | 2,595,257 | SEC↗ |
| NEOT Neothetics, Inc. | S Sale | 2014-11-25 | 2014-11-25 | 57,143 | $14.00 | $800.0K | 2,538,114 | SEC↗ |
| NEOT Neothetics, Inc. | X Exercise | 2014-11-25 | 2014-11-25 | 115,925 | $8.54 | $990.0K | 2,654,039 | SEC↗ |
| NEOT Neothetics, Inc. | S Sale | 2014-11-25 | 2014-11-25 | 70,714 | $14.00 | $990.0K | 2,583,325 | SEC↗ |
| NEOT Neothetics, Inc. | X Exercise | 2014-11-25 | 2014-11-25 | 35,128 | $8.54 | $300.0K | 2,618,453 | SEC↗ |
| NEOT Neothetics, Inc. | S Sale | 2014-11-25 | 2014-11-25 | 21,429 | $14.00 | $300.0K | 2,597,024 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion | 2014-11-25 | 2014-11-25 | 122,951 | — | $0 | 126,885 | SEC↗ |
| NEOT Neothetics, Inc. | X Exercise | 2014-11-25 | 2014-12-01 | 93,676 | $8.54 | $800.0K | 2,595,257 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | J Other | 2014-11-17 | 2014-11-19 | 1,492,200 | — | $0 | 1,492,200 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | P Buy | 2014-10-21 | 2014-10-21 | 500,000 | $20.00 | $10.00M | 2,552,189 | SEC↗ |
| PLCSD VIVEVE MEDICAL, INC. | A Award deriv | 2014-09-26 | 2014-09-30 | 47,000 | — | $0 | 47,000 | SEC↗ |
| PLCSD VIVEVE MEDICAL, INC. | P Buy | 2014-09-23 | 2014-09-25 | 1,895,788 | $0.53 | $1.00M | 1,895,788 | SEC↗ |
| IMDZ Immune Design Corp. | C Conversion deriv | 2014-07-29 | 2014-07-31 | 611,620 | — | $0 | 0 | SEC↗ |
| IMDZ Immune Design Corp. | X Exercise deriv | 2014-07-29 | 2014-07-31 | 305,810 | — | $0 | 305,810 | SEC↗ |
| IMDZ Immune Design Corp. | X Exercise deriv | 2014-07-29 | 2014-07-31 | 305,810 | — | $0 | 0 | SEC↗ |
| IMDZ Immune Design Corp. | C Conversion deriv | 2014-07-29 | 2014-07-31 | 305,810 | — | $0 | 0 | SEC↗ |
| IMDZ Immune Design Corp. | C Conversion deriv | 2014-07-29 | 2014-07-31 | 531,843 | — | $0 | 0 | SEC↗ |
| IMDZ Immune Design Corp. | C Conversion deriv | 2014-07-29 | 2014-07-31 | 733,943 | — | $0 | 0 | SEC↗ |
| IMDZ Immune Design Corp. | C Conversion | 2014-07-29 | 2014-07-31 | 611,620 | — | $0 | 1,877,406 | SEC↗ |
| IMDZ Immune Design Corp. | P Buy | 2014-07-29 | 2014-07-31 | 299,559 | $12.00 | $3.59M | 2,482,775 | SEC↗ |
| IMDZ Immune Design Corp. | C Conversion | 2014-07-29 | 2014-07-31 | 733,943 | — | $0 | 733,943 | SEC↗ |
| IMDZ Immune Design Corp. | C Conversion | 2014-07-29 | 2014-07-31 | 305,810 | — | $0 | 2,183,216 | SEC↗ |
| IMDZ Immune Design Corp. | C Conversion | 2014-07-29 | 2014-07-31 | 531,843 | — | $0 | 1,265,786 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | J Other | 2014-07-16 | 2014-07-18 | 3,000,000 | — | $0 | 616,099 | SEC↗ |
| ZSPH ZS Pharma, Inc. | C Conversion deriv | 2014-06-23 | 2014-06-25 | 2,849,703 | — | $0 | 0 | SEC↗ |
| ZSPH ZS Pharma, Inc. | C Conversion deriv | 2014-06-23 | 2014-06-25 | 180,387 | — | $0 | 0 | SEC↗ |
| ZSPH ZS Pharma, Inc. | C Conversion | 2014-06-23 | 2014-06-25 | 3,030,090 | — | $0 | 3,030,090 | SEC↗ |
| ZSPH ZS Pharma, Inc. | P Buy | 2014-06-23 | 2014-06-25 | 200,000 | $18.00 | $3.60M | 3,230,090 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | S Sale | 2014-05-22 | 2014-05-27 | 300,000 | $16.00 | $4.80M | 3,616,099 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2014-05-15 | 2014-05-16 | 5,000 | — | $0 | 5,000 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | C Conversion deriv | 2014-04-01 | 2014-04-01 | 23,507,953 | — | $0 | 0 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | C Conversion deriv | 2014-04-01 | 2014-04-01 | 49,060,606 | — | $0 | 0 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | C Conversion deriv | 2014-04-01 | 2014-04-01 | 26,437,934 | — | $0 | 0 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | P Buy | 2014-04-01 | 2014-04-01 | 155,645 | $12.00 | $1.87M | 2,984,400 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | C Conversion | 2014-04-01 | 2014-04-01 | 2,828,755 | — | $0 | 2,828,755 | SEC↗ |
| TRVN TREVENA INC | C Conversion deriv | 2014-02-05 | 2014-02-07 | 4,840,686 | — | $0 | 0 | SEC↗ |
| TRVN TREVENA INC | C Conversion deriv | 2014-02-05 | 2014-02-07 | 1,950,000 | — | $0 | 0 | SEC↗ |
| TRVN TREVENA INC | C Conversion deriv | 2014-02-05 | 2014-02-07 | 8,400,000 | — | $0 | 0 | SEC↗ |
| TRVN TREVENA INC | C Conversion deriv | 2014-02-05 | 2014-02-07 | 6,000,000 | — | $0 | 0 | SEC↗ |
| TRVN TREVENA INC | P Buy | 2014-02-05 | 2014-02-07 | 472,410 | $7.00 | $3.31M | 3,890,262 | SEC↗ |
| TRVN TREVENA INC | C Conversion | 2014-02-05 | 2014-02-07 | 1,354,838 | — | $0 | 2,322,579 | SEC↗ |
| TRVN TREVENA INC | C Conversion | 2014-02-05 | 2014-02-07 | 967,741 | — | $0 | 967,741 | SEC↗ |
| TRVN TREVENA INC | C Conversion | 2014-02-05 | 2014-02-07 | 314,516 | — | $0 | 2,637,095 | SEC↗ |
| TRVN TREVENA INC | C Conversion | 2014-02-05 | 2014-02-07 | 780,757 | — | $0 | 3,417,852 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion deriv | 2013-10-30 | 2013-11-01 | 223,483 | — | $0 | 223,483 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion deriv | 2013-10-30 | 2013-11-01 | 1,000,000 | — | $0 | 0 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion deriv | 2013-10-30 | 2013-11-01 | 5,000,000 | — | $0 | 0 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion deriv | 2013-10-30 | 2013-11-01 | 1,117,418 | — | $0 | 0 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion deriv | 2013-10-30 | 2013-11-01 | 10,489,738 | — | $0 | 0 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion deriv | 2013-10-30 | 2013-11-01 | 150,000 | — | $0 | 150,000 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion deriv | 2013-10-30 | 2013-11-01 | 750,000 | — | $0 | 0 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion deriv | 2013-10-30 | 2013-11-01 | 5,081,521 | — | $0 | 0 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion | 2013-10-30 | 2013-11-01 | 200,000 | — | $0 | 200,000 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion | 2013-10-30 | 2013-11-01 | 1,000,000 | — | $0 | 1,200,000 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion | 2013-10-30 | 2013-11-01 | 2,097,947 | — | $0 | 3,297,947 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | P Buy | 2013-10-30 | 2013-11-01 | 110,000 | $10.00 | $1.10M | 3,916,099 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion | 2013-10-30 | 2013-11-01 | 508,152 | — | $0 | 3,806,099 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | J Other deriv | 2013-07-01 | 2013-07-01 | 71,237 | — | $0 | 71,237 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | J Other deriv | 2013-07-01 | 2013-07-01 | 497,666 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | C Conversion deriv | 2013-07-01 | 2013-07-01 | 1,816,475 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | C Conversion | 2013-07-01 | 2013-07-01 | 1,816,475 | — | $0 | 1,816,475 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | P Buy | 2013-07-01 | 2013-07-01 | 235,714 | $14.00 | $3.30M | 2,052,189 | SEC↗ |